$PAR

PAR TECHNOLOGY CORP (PAR): Results of Operations and Financial Condition

PAR TECHNOLOGY CORP (PAR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 aex991earningsreleasexq220.htm EX-99.1 Document Exhibit 99.1 FOR RELEASE: CONTACT: New Hartford, NY, August 6, 2026 Christopher R. Byrnes (315) 743-8376 chris_byrnes@partech.com, www.partech.com PAR TECHNOLOGY CORPORATION ANNOUNCES SECOND QUARTER 2026 RESULTS • Quarterl

Original reporting
Published Aug 6, 2026, 8:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PAR
Bullish
high confidence
Mentioned
$PAR
Relevance
9/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PARBullishHigh
01

Why it matters

Traders can reprice PAR based on the raised FY2026 revenue and adjusted EBITDA ranges and the reported acceleration in revenue and ARR, while monitoring margin trends and the KPI reclassification note.

02

Market read

This is a direct earnings and guidance update with quantified targets for Q3 and FY2026, making it actionable for estimate revisions and near-term positioning.

03

What to watch

The filing notes a KPI presentation change (ARR and active sites on a total basis) and discontinued government segment results, which may complicate year-over-year comparisons.

Relevance 9/10Novelty 9/10Timing: after-hours filing and guidance update for Q3 and full-year 2026

Background

PAR Technology filed an 8-K with its Q2 2026 results and an updated outlook, including ARR and active sites metrics and a KPI presentation methodology change.

Company-level read

Ticker impact

$PARBullishHigh confidence
Context

PAR reported Q2 2026 revenue of $133.4M (+19% YoY) and raised FY2026 outlook to $516.0M-$523.0M revenue and $50.0M-$53.0M adjusted EBITDA.

Expected impact

Likely positive near-term bias as raised full-year guidance and accelerating revenue/ARR support expectations for 2H execution.

Evidence & confidence

The 8-K includes new, time-sensitive forward guidance ranges for Q3 and FY2026, alongside reported Q2 results and ARR/active sites figures that directly inform valuation and estimates.

Market effects

Signals improving profitability and scaling of subscription/recurring revenue for restaurant and high-volume commerce software providers.

Primarily US-listed software earnings impact; limited direct regional spillover beyond investor sentiment for the group.

Moderate, as the company’s guidance is company-specific and not tied to global macro policy.

Counterpoint

Gross margin and subscription service gross margin were slightly worse on a percentage basis, which could temper enthusiasm despite revenue growth and guidance raises.

Key entities

  • PAR Technology Corporation

    Company reporting Q2 2026 results, ARR/active sites, and raised Q3 and FY2026 guidance in an SEC 8-K.

  • Savneet Singh

    CEO quoted on accelerating revenue, increasing profitability, and progress toward deploying PAR Intelligence to 50,000 sites by year end.

Related articles

$LDOSMedAI 8/10

12 Companies Win Spots on DHS $1.5B Counter-Drone IDIQ

DHS awarded 14 positions on a $1.5B counter-drone IDIQ, split into Track 1 (ceiling $1.01B) for hardware and services and Track 2 (ceiling $489M) for comprehensive services, per USAspending. Leidos and BAE Systems won both tracks; others received single-track spots. Ordering runs Aug. 1, 2026 to July 31, 2031, with a $250M minimum guarantee at award.

$CGTXMed

COGNITION THERAPEUTICS INC (CGTX): Results of Operations and Financial Condition

COGNITION THERAPEUTICS INC (CGTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622462d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update Purchase, NY – August 6, 2026 – Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing pr

$BARKMed

Bark, Inc. (BARK): Results of Operations and Financial Condition

Bark, Inc. (BARK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q1fy27earningsrelease.htm EX-99.1 Document BARK Reports Fiscal First Quarter 2027 Results NEW YORK, August 6, 2026 — BARK, Inc. (NYSE: BARK) (“BARK” or the “Company”), a leading global omnichannel dog brand with a mission to make all dogs happy, today announced its fina

$VHIMed

VALHI INC /DE/ (VHI): Results of Operations and Financial Condition

VALHI INC /DE/ (VHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 vhl-20260806xex99d1.htm EX-99.1 ‌ ​ ​ ​ ‌ ​ ​ ​ ​ VALHI REPORTS SECOND QUARTER 2026 RESULTS ​ DALLAS, TEXAS . . August 6, 2026. Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $22.3 million, or $.78 per share, in the second quarter of 2